GlobalData on MSN

Guardant and MSD collaborate on companion diagnostics development

"Guardant and MSD collaborate on companion diagnostics development" was originally created and published by Hospital ...

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapie…

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year collaboration with ...
PharmiWeb

Merck to Complete Acquisition of Cidara Therapeutics in $9.2 Billion Deal

Merck (known as MSD outside of the United States and Canada) will complete its $9.2 billion acquisition of Cidara ...
GlobalData on MSN

MSD begins KANDLELIT-007 trial of calderasib for NSCLC

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Pharmabiz

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in ...

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in patients with high-risk stage ...
Pharmabiz

NIH, Merck and Gates MRI completes phase I trial of TBD09/MK-7762 TB drug candidate

NIH, Merck and Gates MRI completes phase I trial of TBD09/MK-7762 TB drug candidate: Our Bureau, Bengaluru Wednesday, January 14, 2026, 14:45 Hrs [IST] Merck, known as MSD outside ...